2025-01-24 2026-01-31 2026-01-31 false 16207501 Kerr Roche Ltd 86210General medical practice activities iso4217:GBP xbrli:pure 162075012025-01-24 162075012026-01-31 162075012025-01-24 2026-01-31 16207501bus:Micro-entities2025-01-24 2026-01-31 16207501bus:AuditExempt-NoAccountantsReport2025-01-24 2026-01-31 16207501bus:FullAccounts2025-01-24 2026-01-31 16207501core:WithinOneYear2026-01-31 16207501core:AfterOneYear2026-01-31 16207501core:WithinOneYear2025-01-24 2026-01-31 16207501core:AfterOneYear2025-01-24 2026-01-31 16207501core:CurrentFinancialInstruments2026-01-31 16207501core:Non-currentFinancialInstruments2026-01-31 16207501core:CurrentFinancialInstruments2025-01-24 2026-01-31 16207501core:Non-currentFinancialInstruments2025-01-24 2026-01-31 16207501core:LandBuildings2025-01-24 2026-01-31 16207501core:FurnitureFittings2025-01-24 2026-01-31 16207501core:OfficeEquipment2025-01-24 2026-01-31 16207501core:Vehicles2025-01-24 2026-01-31 16207501core:PlantMachinery2025-01-24 2026-01-31 16207501core:OtherPropertyPlantEquipment2025-01-24 2026-01-31 16207501core:LandBuildings2026-01-31 16207501core:PlantMachinery2026-01-31 16207501core:Vehicles2026-01-31 16207501core:FurnitureFittings2026-01-31 16207501core:OfficeEquipment2026-01-31 16207501core:OtherPropertyPlantEquipment2026-01-31 16207501core:Right-of-useAssets2025-01-24 2026-01-31 16207501core:Right-of-useAssets2026-01-31 16207501core:Goodwill2025-01-24 2026-01-31 16207501core:PatentsTrademarksLicencesConcessionsSimilar2025-01-24 2026-01-31 16207501core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-24 2026-01-31 16207501core:OtherResidualIntangibleAssets2025-01-24 2026-01-31 16207501core:Goodwill2026-01-31 16207501core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-01-31 16207501core:PatentsTrademarksLicencesConcessionsSimilar2026-01-31 16207501core:OtherResidualIntangibleAssets2026-01-31 16207501dpl:CostSales2025-01-24 2026-01-31 16207501dpl:AdministrativeExpenses2025-01-24 2026-01-31 16207501dpl:DistributionCosts2025-01-24 2026-01-3116207501bus:Director12025-01-24 2026-01-3116207501bus:PrivateLimitedCompanyLtd2025-01-24 2026-01-31
Kerr Roche Ltd
Unaudited Financial Statements
for the period ended 31 January 2026
Company registration number 16207501
(England and Wales)

Company Information

For the period 24 January 2025 to 31 January 2026
Director Karon, Katarzyna Anna

Registered office 20 Wenlock Road
London
N1 7GU

Registered number 16207501

Accountant James Taylor
10 Hathaway Close
Stanmore
Middlesex
HA7 3NR

Statement of Financial Position

As at 31 January 2026
2026
£
£
Prepayments and accrued income
1,913
Creditors amounts falling due within one year
(1,090)
Net current assets (liabilities)
823
Total assets less current liabilities
823
Net assets (liabilities)
823
Capital and reserves
823

Notes to the Financial Statements

1. Employees

The average number of employees during the year was 0.
The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and authorised for issue by the director on 27 August 2026 and are signed on its behalf by:

Karon, Katarzyna Anna
Karon, Katarzyna Anna
Director

Company registration number 16207501